realize that we've been in the dog house for a couple of years so this can bounce higher than you'd expect as finally they've turned the corner. The first domino to fall ;)
I grabbed this from the Stockhouse board:
additional potential milestone payments of up to US$138 million
->that's about $2 Cdn/share just in milestone payments
and royalties on net sales from licensed products.
->that's additional monies on top of the milestones
Chiesi Global Rare Diseases and Bioasis will host a joint webcast with details to be announced.
->i'm very excited that the pharma is proud of this partnership so much so that they are
->wanting to host a joint webcast for shareholders, their company followers, and the press.
->Chiese is a private company and had 1.768 billion EUR of revenue in 2018